GINO BIOW Stock Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Sales 2024 * | 223M 305M | Sales 2025 * | 310M 423M | Capitalization | 1.72B 2.35B |
---|---|---|---|---|---|
Net income 2024 * | -631M -863M | Net income 2025 * | -534M -730M | EV / Sales 2024 * | 4.68 x |
Net cash position 2024 * | 676M 924M | Net cash position 2025 * | 550M 751M | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
-2.69
x | P/E ratio 2025 * |
-3.17
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.98% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 07-12-31 |
Founder | - | 07-12-31 | |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 21-09-15 |
Marijn Dekkers
CHM | Chairman | 65 | 21-09-15 |
Kathy Hannan
BRD | Director/Board Member | 62 | 22-08-01 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |